Agios Pharmaceuticals, Inc. (AGIO) Financials

AGIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.1 billion 82.4 million
March 31, 2026 1.2 billion 75.9 million
Dec. 31, 2025 1.3 billion 104.1 million
Sept. 30, 2025 1.4 billion 101.4 million

AGIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -58.5 million 15.9 million
March 31, 2026 -119.7 million 15.5 million
Dec. 31, 2025 -97.3 million 14.1 million
Sept. 30, 2025 -89.7 million 12.4 million

AGIO Net Income

No data available :(

AGIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 617.6 million - 31.2 million
March 31, 2026 737.0 million - 35.7 million
Dec. 31, 2025 854.4 million - 40.2 million
Sept. 30, 2025 952.9 million - 44.5 million

AGIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 59.5 million
March 31, 2026 58.8 million
Dec. 31, 2025 58.3 million
Sept. 30, 2025 58.1 million

AGIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.2 million 100.8 million 51.5 million -
March 31, 2026 769000 79.8 million 48.3 million -
Dec. 31, 2025 1.1 million 86.8 million 51.6 million -
Sept. 30, 2025 1.6 million 85.4 million 41.3 million -

AGIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 44.7 million 3.0 million
March 31, 2026 20.7 million 2.7 million
Dec. 31, 2025 20.0 million 3.1 million
Sept. 30, 2025 12.9 million 3.1 million

AGIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AGIO

Price: $33.56

52 week price:
22.24
46.00

Earnings Per Share: -7.04 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 44002

Ebitda: -88.5 million

Market Capitalization: 1.9 billion

Links: